EVIFX
Price
$12.57
Change
+$0.07 (+0.56%)
Updated
Aug 6 closing price
Net Assets
1.07B
RLBCX
Price
$36.79
Change
-$0.02 (-0.05%)
Updated
Aug 7 closing price
Net Assets
253.12B
Interact to see
Advertisement

EVIFX vs RLBCX

Header iconEVIFX vs RLBCX Comparison
Open Charts EVIFX vs RLBCXBanner chart's image
Eaton Vance Balanced A
Price$12.57
Change+$0.07 (+0.56%)
VolumeN/A
Net Assets1.07B
American Funds American Balanced R3
Price$36.79
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets253.12B
EVIFX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EVIFX vs. RLBCX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVIFX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 253B vs. EVIFX (1.07B). RLBCX pays higher dividends than EVIFX: RLBCX (1.56) vs EVIFX (1.21). EVIFX was incepted earlier than RLBCX: EVIFX (93 years) vs RLBCX (23 years). EVIFX (0.97) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. EVIFX (5.00). RLBCX has a lower initial minimum investment than EVIFX: RLBCX (250) vs EVIFX (1000). RLBCX annual gain was more profitable for investors over the last year : 11.04 vs. EVIFX (10.33). RLBCX return over 5 years is better than : 34.79 vs. EVIFX (26.95).
EVIFXRLBCXEVIFX / RLBCX
Total Expense Ratio0.970.89109%
Annual Report Gross Expense Ratio0.970.89109%
Fund Existence93 years23 years-
Gain YTD6.7318.35981%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B253B0%
Annual Yield % from dividends1.211.5678%
Returns for 1 year10.3311.0494%
Returns for 3 years27.7829.8493%
Returns for 5 years26.9534.7977%
Returns for 10 years62.4260.65103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APRE1.650.01
+0.61%
Aprea Therapeutics
CFG46.64-0.29
-0.62%
Citizens Financial Group
CMPS4.31-0.05
-1.15%
COMPASS Pathways Plc
CNTB2.07-0.06
-2.82%
Connect Biopharma Holdings Limited
LRN144.05-4.27
-2.88%
Stride